Success Metrics

Clinical Success Rate

100.0%

Based on 6 completed trials

Completion Rate

100%(6/6)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

17%

Ph phase_3

33%

Ph phase_4

33%

Ph phase_2

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 2Efficacy & side effects

1(16.7%)

Phase 3Large-scale testing

2(33.3%)

Phase 4Post-market surveillance

2(33.3%)

N/ANon-phased studies

1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (16.7%)

Phase 32 (33.3%)

Phase 42 (33.3%)

N/A1 (16.7%)

Trials by Status

completed6100%

Recent Activity

0 active trials

Showing 5 of 6

completedphase_4

Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years

NCT01396889

completedphase_2

Evaluation of Echinacea for the Common Cold

NCT00032500

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT01046890Phase 4

Drug Interactions Between Echinacea Purpurea and Darunavir/Ritonavir

Completed

NCT00065715Phase 3

Echinacea Versus Placebo Effect in Common Cold (Physician Echinacea Placebo)

Completed

NCT01021995Phase 4

Echinacea Safety Study

Completed

NCT01396889Not Applicable

Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years

Completed

NCT00032500Phase 2

Evaluation of Echinacea for the Common Cold

Completed

NCT00029211Phase 3

A Trial of Echinacea in Children

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6